Positive Ergebnisse aus Phase-III-Studien zu oralem TYK2-Inhibitor bei Psoriasis

View at publisher Summarise with VIRAT
Authors: Redaktion Facharztmagazine
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Spondyloarthritis Studies and Treatments

Publication details

Journal / source
hautnah dermatologie
Volume
42
Issue
2
Pages
72–72
Publication date
1 March 2026
Language
DE